Therapeutic Effect of Oncolytic Herpes Simplex Virus Type 1 (G47Δ) in Combination with Chemotherapy on Colorectal Cancer

被引：1
|
作者：
Abe, Shinya [1 ]
Ino, Yasushi [1 ]
Fukuhara, Hiroshi [2 ]
Iwai, Miwako [1 ]
Watanabe, Toshiaki [3 ]
Todo, Tomoki [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Tokyo, Japan
[3] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33472-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
664
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [31] The efficacy of oncolytic virus therapy using G47 Δ in mouse biliary tract cancer models
    Tateno, Yoko
    Ino, Yasushi
    Iwai, Miwako
    Shinozaki, Masaru
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 1392 - 1392
  • [32] Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
    Yin, Lei
    Zhao, Chunhong
    Han, Jixia
    Li, Zengjun
    Zhen, Yanan
    Xiao, Ruixue
    Xu, Zhongfa
    Sun, Yanlai
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 117 - 130
  • [33] Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
    Jiani Wang
    Lihua Xu
    Weigen Zeng
    Pan Hu
    Musheng Zeng
    Samuel D Rabkin
    Renbin Liu
    Cancer Cell International, 14
  • [34] An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer
    Fu, X.
    Tao, L.
    Zhang, X.
    CANCER GENE THERAPY, 2007, 14 (05) : 480 - 487
  • [35] Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
    Wang, Jiani
    Xu, Lihua
    Zeng, Weigen
    Hu, Pan
    Zeng, Musheng
    Rabkin, Samuel D.
    Liu, Renbin
    CANCER CELL INTERNATIONAL, 2014, 14
  • [36] An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer
    X Fu
    L Tao
    X Zhang
    Cancer Gene Therapy, 2007, 14 : 480 - 487
  • [37] Oncolytic herpes simplex virus vector G47D in combination with androgen ablation for the treatment of human prostate adenocarcinoma
    Fukuhara, H
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 387 - 388
  • [38] Oncolytic herpes simplex virus type 1 and host immune responses
    Fukuhara, Hiroshi
    Todo, Tomoki
    CURRENT CANCER DRUG TARGETS, 2007, 7 (02) : 149 - 155
  • [39] Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms
    Oku, Maki
    Ishino, Ryo
    Uchida, Shumpei
    Imataki, Osamu
    Sugimoto, Naoshi
    Todo, Tomoki
    Kadowaki, Norimitsu
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (02) : 343 - 353
  • [40] A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
    Tomoki Todo
    Yasushi Ino
    Hiroshi Ohtsu
    Junji Shibahara
    Minoru Tanaka
    Nature Communications, 13
12345